Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications
Targeting of Wnt-β-Catenin Pathway in Recurrent Ameloblastoma.
Journal: The New England journal of medicine
Published: June 03, 2026
TP53 mutation is associated with improved disease control in patients with advanced RAS wild-type colorectal adenocarcinoma treated with cetuximab and pembrolizumab.
Journal: International journal of cancer
Published: July 17, 2025
NP-101 in combination with nivolumab and ipilimumab in metastatic extrapulmonary neuroendocrine carcinomas (EP-NECs): A pilot study.
Journal: Endocrine-related cancer
Published: July 10, 2025
Surgical cytoreduction versus systemic therapy in patients with metastatic gastroenteropancreatic neuroendocrine neoplasms (GEP-NENS): a national cancer database analysis (NCDB).
Journal: Oncology reviews
Published: March 07, 2025
Tucatinib plus trastuzumab for chemotherapy-refractory, HER2 + , RAS wild-type metastatic colorectal cancer (MOUNTAINEER): final analysis.
Journal: Nature communications
Published: March 06, 2025
Real-World Tolerability of Capecitabine and Oxaliplatin in Patients in the United States With Localized Colorectal Cancer Undergoing Curative-Intent Treatment.
Journal: JCO oncology practice
Published: March 04, 2025
Phase I study of allogeneic monocyte-derived inflammatory dendritic cells in combination with pembrolizumab.
Journal: Future science OA
Published: November 20, 2024
CITRINO: phase 1 dose escalation study of anti-LAG-3 antibody encelimab alone or in combination with anti-PD-1 dostarlimab in patients with advanced/metastatic solid tumours.
Journal: BJC reports
Published: August 15, 2024
Devimistat (CPI-613) With Modified Fluorouarcil, Oxaliplatin, Irinotecan, and Leucovorin (FFX) Versus FFX for Patients With Metastatic Adenocarcinoma of the Pancreas: The Phase III AVENGER 500 Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 01, 2024
Safety and Efficacy of Toripalimab in Patients with Cholangiocarcinoma: An Open-Label, Phase 1 Study.
Journal: Journal of immunotherapy and precision oncology
Published: March 14, 2024
Outcomes of Hepatic Artery-Based Therapies and Systemic Multiagent Chemotherapy in Unresectable Colorectal Liver Metastases: A Systematic Review and Meta-analysis.
Journal: Annals of surgical oncology
Published: January 25, 2024
Last Updated: 09/26/2026